Modulation of human motor cortex excitability by the cholinesterase inhibitor rivastigmine

Neuroscience Letters

Volumn 415, Issue 1, 2007, Pages 40-44

  Langguth, Berthold ^a   Bauer, Elena ^a   Feix, Sebastian ^a   Landgrebe, Michael ^a   Binder, Harald ^b   Sand, Philipp ^a   Hajak, Göran ^a   Eichhammer, Peter ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cholinesterase inhibitor; Excitability; Human motor cortex; Rivastigmine; Transcranial magnetic stimulation

Indexed keywords

CHOLINESTERASE INHIBITOR; RECEPTOR SUBTYPE; RIVASTIGMINE;

ARTICLE; DRUG WITHDRAWAL; EVOKED MUSCLE RESPONSE; FACILITATION; HAND MUSCLE; HUMAN; HUMAN EXPERIMENT; LOADING DRUG DOSE; MOTOR CORTEX; NAUSEA; NERVE EXCITABILITY; NORMAL HUMAN; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; STIMULUS RESPONSE; TRANSCRANIAL MAGNETIC STIMULATION;

ACETYLCHOLINE; ACTION POTENTIALS; ADULT; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MALE; MOTOR CORTEX; MOVEMENT; NERVE NET; NEURAL PATHWAYS; NEURONS; PHENYLCARBAMATES; SYNAPTIC TRANSMISSION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 33847630793     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.01.008     Document Type: Article

References (22)

1. Ballmaier M., Casamenti F., Scali C., Mazzoncini R., Zoli M., Pepeu G., and Spano P.F. Rivastigmine antagonizes deficits in prepulse inhibition induced by selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis. Neuroscience 114 (2002) 91-98
2. Devanne H., Lavoie B.A., and Capaday C. Input-output properties and gain changes in the human corticospinal pathway. Exp. Brain Res. 114 (1997) 329-338
3. Di Lazzaro V., Oliviero A., Pilato F., Saturno E., Dileone M., Marra C., Daniele A., Ghirlanda S., Gainotti G., and Tonali P.A. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 75 (2004) 555-559
4. Di Lazzaro V., Oliviero A., Profice P., Pennisi M.A., Di Giovanni S., Zito G., Tonali P., and Rothwell J.C. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp. Brain Res. 135 (2000) 455-461
5. Di Lazzaro V., Oliviero A., Profice P., Saturno E., Pilato F., Insola A., Mazzone P., Tonali P., and Rothwell J.C. Comparison of descending volleys evoked by transcranial magnetic and electric stimulation in conscious humans. Electroencephalogr. Clin. Neurophysiol. 109 (1998) 397-401
6. Di Lazzaro V., Oliviero A., Tonali P.A., Marra C., Daniele A., Profice P., Saturno E., Pilato F., Masullo C., and Rothwell J.C. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 59 (2002) 392-397
7. Kennedy J.S., Polinsky R.J., Johnson B., Loosen P., Enz A., Laplanche R., Schmidt D., Mancione L.C., Parris W.C., and Ebert M.H. Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humans. J. Clin. Psychopharmacol. 19 (1999) 513-521
8. Kimura F. Cholinergic modulation of cortical function: a hypothetical role in shifting the dynamics in cortical network. Neurosci. Res. 38 (2000) 19-26
9. Korchounov A., Ilic T.V., Schwinge T., and Ziemann U. Modification of motor cortical excitability by an acetylcholinesterase inhibitor. Exp. Brain Res. 164 (2005) 399-405
10. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., Wroe S., Asselman P., and Marsden C.D. Corticocortical inhibition in human motor cortex. J. Physiol. 471 (1993) 501-519
11. Liepert J., Bar K.J., Meske U., and Weiller C. Motor cortex disinhibition in Alzheimer's disease. Clin. Neurophysiol. 112 (2001) 1436-1441
12. Liepert J., Schardt S., and Weiller C. Orally administered atropine enhances motor cortex excitability: a transcranial magnetic stimulation study in human subjects. Neurosci. Lett. 300 (2001) 149-152
13. Mittmann T., and Alzheimer C. Muscarinic inhibition of persistent Na+ current in rat neocortical pyramidal neurons. J. Neurophysiol. 79 (1998) 1579-1582
14. Pepin J.L., Bogacz D., de Pasqua V., and Delwaide P.J. Motor cortex inhibition is not impaired in patients with Alzheimer's disease: evidence from paired transcranial magnetic stimulation. J. Neurol. Sci. 170 (1999) 119-123
15. Ridding M.C., and Rothwell J.C. Stimulus/response curves as a method of measuring motor cortical excitability in man. Electroencephalogr. Clin. Neurophysiol. 105 (1997) 340-344
16. Role L.W., and Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16 (1996) 1077-1085
17. Sawaki L., Boroojerdi B., Kaelin-Lang A., Burstein A.H., Butefisch C.M., Kopylev L., Davis B., and Cohen L.G. Cholinergic influences on use-dependent plasticity. J. Neurophysiol. 87 (2002) 166-171
18. Smith M.J., Adams L.F., Schmidt P.J., Rubinow D.R., and Wassermann E.M. Effects of ovarian hormones on human cortical excitability. Ann. Neurol. 51 (2002) 599-603
19. Snape M.F., Misra A., Murray T.K., De Souza R.J., Williams J.L., Cross A.J., and Green A.R. A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066. Neuropharmacology 38 (1999) 181-193
20. Vidal C., and Changeux J.P. Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro. Neuroscience 56 (1993) 23-32
21. Williams B.R., Nazarians A., and Gill M.A. A review of rivastigmine: a reversible cholinesterase inhibitor. Clin Ther. 25 (2003) 1634-1653
22. Xiang Z., Huguenard J.R., and Prince D.A. Cholinergic switching within neocortical inhibitory networks. Science 281 (1998) 985-988